Where does novel antibiotics R&D stand among other pharmaceutical products: an industrial perspective?

被引：3

作者：

Tillotson, Glenn S. ^{[1
]}

机构：

[1] Viropharma Inc, Med Affairs US, Exton, PA 19341 USA

来源：

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2008年 / 6卷 / 05期

关键词：

D O I：

10.1586/14787210.6.5.551

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：551 / 552

页数：2

共 7 条

[1]

[Anonymous], GUIDANCE IND E14 CLI

[2] Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship [J].

Dellit, Timothy H. ;

Owens, Robert C. ;

McGowan, John E., Jr. ;

Gerding, Dale N. ;

Weinstein, Robert A. ;

Burke, John P. ;

Huskins, W. Charles ;

Paterson, David L. ;

Fishman, Neil O. ;

Carpenter, Christopher F. ;

Brennan, P. J. ;

Billeter, Marianne ;

Hooton, Thomas M. .

CLINICAL INFECTIOUS DISEASES, 2007, 44 (02) :159-177

[3] A Comparative Study on the Cost of New Antibiotics and Drugs of Other Therapeutic Categories [J].

Falagas, Matthew E. ;

Fragoulis, Konstantinos N. ;

Karydis, Ioannis .

PLOS ONE, 2006, 1 (01)

[4] Community-acquired pneumonia mortality: a potential link to antibiotic prescribing trends in general practice [J].

Price, DB ;

Honeybourne, D ;

Little, P ;

Mayon-White, RT ;

Read, RC ;

Thomas, M ;

Wale, MC ;

Fitzgerald, P ;

Weston, AR ;

Winchester, CC .

RESPIRATORY MEDICINE, 2004, 98 (01) :17-24

[5] Why is big Pharma getting out of antibacterial drug discovery? [J].

Projan, SJ .

CURRENT OPINION IN MICROBIOLOGY, 2003, 6 (05) :427-430

[6] The epidemic of antibiotic-resistant infections: A call to action for the medical community from the Infectious Diseases Society of America [J].

Spellberg, Brad ;

Guidos, Robert ;

Gilbert, David ;

Bradley, John ;

Boucher, Helen W. ;

Scheld, W. Michael ;

Bartlett, John G. ;

Edwards, John, Jr. .

CLINICAL INFECTIOUS DISEASES, 2008, 46 (02) :155-164

[7]

2008, PUBL WORKSH JAN 17 1

← 1 →